10x Genomics News 7 may 2026 10x Genomics (NASDAQ:TXG) Beats Q1 Estimates But Falls as Revenue Shrinks Year-Over-Year - ChartMill
Siemens Healthineers 7 may 2026 Siemens Healthineers lowers 2026 outlook due to China conditions, inflation - MassDevice
10x Genomics News 7 may 2026 10x Genomics (TXG) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
10x Genomics Blog 7 may 2026 10x Genomics’s (NASDAQ:TXG) Q1 CY2026: Beats On Revenue But Stock Drops - StockStory
10x Genomics Blog 7 may 2026 Q1 2026: 10x Genomics (NASDAQ: TXG) narrows loss, launches Atera - Stock Titan
Siemens Healthineers 7 may 2026 Slump in China’s diagnostics division: Siemens lowers its revenue forecasts - Table.Briefings
Merck & Co. 7 may 2026 Merck & Co Completes $5.3-Bn Acquisition of Terns Pharmaceuticals - DCAT Value Chain Insights
Clinical OMICs 7 may 2026 Broader Immune Targeting Increases Immunotherapy Benefit in Colorectal Cancer